159 related articles for article (PubMed ID: 33080736)
21. The role of readout-segmented echo-planar imaging-based diffusion-weighted imaging in evaluating tumor response of locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
Yang L; Xia C; Liu D; Fang X; Pan X; Ma L; Wu B
Acta Radiol; 2020 Sep; 61(9):1155-1164. PubMed ID: 31924105
[TBL] [Abstract][Full Text] [Related]
22. Dynamic contrast enhanced MR imaging for rectal cancer response assessment after neo-adjuvant chemoradiation.
Intven M; Reerink O; Philippens ME
J Magn Reson Imaging; 2015 Jun; 41(6):1646-53. PubMed ID: 25124320
[TBL] [Abstract][Full Text] [Related]
23. Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy.
Iannicelli E; Di Pietropaolo M; Pilozzi E; Osti MF; Valentino M; Masoni L; Ferri M
Abdom Radiol (NY); 2016 Oct; 41(10):1906-17. PubMed ID: 27323759
[TBL] [Abstract][Full Text] [Related]
24. Exploring MR regression patterns in rectal cancer during neoadjuvant radiochemotherapy with daily T2- and diffusion-weighted MRI.
Bostel T; Dreher C; Wollschläger D; Mayer A; König F; Bickelhaupt S; Schlemmer HP; Huber PE; Sterzing F; Bäumer P; Debus J; Nicolay NH
Radiat Oncol; 2020 Jul; 15(1):171. PubMed ID: 32653003
[TBL] [Abstract][Full Text] [Related]
25. MRI predictive factors for tumor response in rectal cancer following neoadjuvant chemoradiation therapy--implications for induction chemotherapy?
Yu SK; Tait D; Chau I; Brown G
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):505-11. PubMed ID: 24074924
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic performance of MRI for prediction of candidates for local excision of rectal cancer (ypT0-1N0) after neoadjuvant chemoradiation therapy.
Kim JG; Song KD; Kim SH; Kim HC; Huh JW
J Magn Reson Imaging; 2016 Aug; 44(2):471-7. PubMed ID: 26800999
[TBL] [Abstract][Full Text] [Related]
27. Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR).
Gampenrieder SP; Peer A; Weismann C; Meissnitzer M; Rinnerthaler G; Webhofer J; Westphal T; Riedmann M; Meissnitzer T; Egger H; Klaassen Federspiel F; Reitsamer R; Hauser-Kronberger C; Stering K; Hergan K; Mlineritsch B; Greil R
Breast Cancer Res; 2019 Jan; 21(1):19. PubMed ID: 30704493
[TBL] [Abstract][Full Text] [Related]
28. Effect of increasing radiation dose on pathologic complete response in rectal cancer patients treated with neoadjuvant chemoradiation therapy.
Hall MD; Schultheiss TE; Smith DD; Fakih MG; Wong JY; Chen YJ
Acta Oncol; 2016 Dec; 55(12):1392-1399. PubMed ID: 27762654
[TBL] [Abstract][Full Text] [Related]
29. Assessment of Clinical Complete Response After Chemoradiation for Rectal Cancer with Digital Rectal Examination, Endoscopy, and MRI: Selection for Organ-Saving Treatment.
Maas M; Lambregts DM; Nelemans PJ; Heijnen LA; Martens MH; Leijtens JW; Sosef M; Hulsewé KW; Hoff C; Breukink SO; Stassen L; Beets-Tan RG; Beets GL
Ann Surg Oncol; 2015 Nov; 22(12):3873-80. PubMed ID: 26198074
[TBL] [Abstract][Full Text] [Related]
30. Profiling of rectal cancers MRI in pathological complete remission states after neoadjuvant concurrent chemoradiation therapy.
Kim H; Kim HM; Koom WS; Kim NK; Kim MJ; Kim H; Hur H; Lim JS
Clin Radiol; 2016 Mar; 71(3):250-7. PubMed ID: 26747329
[TBL] [Abstract][Full Text] [Related]
31. Developing a prediction model based on MRI for pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Wan L; Zhang C; Zhao Q; Meng Y; Zou S; Yang Y; Liu Y; Jiang J; Ye F; Ouyang H; Zhao X; Zhang H
Abdom Radiol (NY); 2019 Sep; 44(9):2978-2987. PubMed ID: 31327039
[TBL] [Abstract][Full Text] [Related]
32. Predictors of Pathologic Complete Response in Rectal Cancer Patients Undergoing Total Mesorectal Excision After Preoperative Chemoradiation.
Han YD; Kim WR; Park SW; Cho MS; Hur H; Min BS; Baik SH; Lee KY; Kim NK
Medicine (Baltimore); 2015 Nov; 94(45):e1971. PubMed ID: 26559272
[TBL] [Abstract][Full Text] [Related]
33. Pretreatment Tumor Thickness as a Predictor of Pathologic Complete Response to Neoadjuvant Chemoradiation Therapy for Stage II/III Rectal Adenocarcinoma.
Xu B; Chen Y; Guo Y; Zhou D; Yue Z; Duan Q; Yang Y; Guan G; Chi P; Lin C
Am J Clin Oncol; 2018 Jun; 41(6):601-606. PubMed ID: 27672742
[TBL] [Abstract][Full Text] [Related]
34. Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Cui Y; Yang X; Shi Z; Yang Z; Du X; Zhao Z; Cheng X
Eur Radiol; 2019 Mar; 29(3):1211-1220. PubMed ID: 30128616
[TBL] [Abstract][Full Text] [Related]
35. Locally advanced rectal cancer: qualitative and quantitative evaluation of diffusion-weighted magnetic resonance imaging in restaging after neoadjuvant chemo-radiotherapy.
Napoletano M; Mazzucca D; Prosperi E; Aisa MC; Lupattelli M; Aristei C; Scialpi M
Abdom Radiol (NY); 2019 Nov; 44(11):3664-3673. PubMed ID: 31004202
[TBL] [Abstract][Full Text] [Related]
36. Accuracy of positron emission tomography/computed tomography and clinical assessment in the detection of complete rectal tumor regression after neoadjuvant chemoradiation: long-term results of a prospective trial (National Clinical Trial 00254683).
Perez RO; Habr-Gama A; Gama-Rodrigues J; Proscurshim I; Julião GP; Lynn P; Ono CR; Campos FG; Silva e Sousa AH; Imperiale AR; Nahas SC; Buchpiguel CA
Cancer; 2012 Jul; 118(14):3501-11. PubMed ID: 22086847
[TBL] [Abstract][Full Text] [Related]
37. Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT.
Shanmugan S; Arrangoiz R; Nitzkorski JR; Yu JQ; Li T; Cooper H; Konski A; Farma JM; Sigurdson ER
Ann Surg Oncol; 2012 Jul; 19(7):2178-85. PubMed ID: 22395978
[TBL] [Abstract][Full Text] [Related]
38. Magnetic resonance imaging following neoadjuvant chemoradiation and transanal endoscopic microsurgery for rectal cancer.
São Julião GP; Ortega CD; Vailati BB; Habr-Gama A; Fernandez LM; Gama-Rodrigues J; Araujo SE; Perez RO
Colorectal Dis; 2017 Jun; 19(6):O196-O203. PubMed ID: 28436197
[TBL] [Abstract][Full Text] [Related]
39. Predictive Significance of Mucinous Histology on Pathologic Complete Response Rate Following Capecitabine-Based Neoadjuvant Chemoradiation in Rectal Cancer: a Comparative Study.
Hosseini S; Nguyen N; Mohammadianpanah M; Mirzaei S; Bananzadeh AM
J Gastrointest Cancer; 2019 Dec; 50(4):716-722. PubMed ID: 29984382
[TBL] [Abstract][Full Text] [Related]
40. Pelvic MRI after induction chemotherapy and before long-course chemoradiation therapy for rectal cancer: What are the imaging findings?
Gollub MJ; Blazic I; Bates DDB; Campbell N; Knezevic A; Gonen M; Lynn P; Weiser MR; Garcia-Aguilar J; Hötker AM; Cercek A; Saltz L
Eur Radiol; 2019 Apr; 29(4):1733-1742. PubMed ID: 30280248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
